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Abstract
Our previous studies showed that an extract from Camellia sinenesis (green tea), which contains several polyphenols,
attenuates nephrotoxicity caused by cyclosporine A (CsA). Since polyphenols are stimulators of mitochondrial biogenesis
(MB), this study investigated whether stimulation of MB plays a role in green tea polyphenol protection against CsA renal
toxicity. Rats were fed a powdered diet containing green tea polyphenolic extract (0.1%) starting 3 days prior to CsA
treatment (25 mg/kg, i.g. daily for 3 weeks). CsA alone decreased renal nuclear DNA-encoded oxidative phosphorylation
(OXPHOS) protein ATP synthase-b (AS-b) by 42%, mitochondrial DNA (mtDNA)-encoded OXPHOS protein NADH
dehydrogenase-3 (ND3) by 87% and their associated mRNAs. Mitochondrial DNA copy number was also decreased by
78% by CsA. Immunohistochemical analysis showed decreased cytochrome c oxidase subunit IV (COX-IV), an OXPHOS
protein, in tubular cells. Peroxisome proliferator-activated receptor-c coactivator (PGC)-1a, the master regulator of MB, and
mitochondrial transcription factor-A (Tfam), the transcription factor that regulates mtDNA replication and transcription,
were 42% and 90% lower, respectively, in the kidneys of CsA-treated than in untreated rats. These results indicate
suppression of MB by chronic CsA treatment. Green tea polyphenols alone and following CsA increased AS-b, ND3, COX-IV,
mtDNA copy number, PGC-1a mRNA and protein, decreased acetylated PGC-1a, and increased Tfam mRNA and protein. In
association with suppressed MB, CsA increased serum creatinine, caused loss of brush border and dilatation of proximal
tubules, tubular atrophy, vacuolization, apoptosis, calcification, and increased neutrophil gelatinase-associated lipocalin
expression, leukocyte infiltration, and renal fibrosis. Green tea polyphenols markedly attenuated CsA-induced renal injury
and improved renal function. Together, these results demonstrate that green tea polyphenols attenuate CsA-induced
kidney injury, at least in part, through the stimulation of MB.
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Introduction
Cyclosporin A (CsA) is an important immunosuppressive agent.
Even with the development of new immunosuppressants, CsA is
still widely used after organ transplantation and for treatment of
autoimmune diseases [1–3]. Immunosuppressive therapy with CsA
is always long-term and results in a number of side effects, the most
frequent and severe being nephrotoxicity (e.g. renal dysfunction in
up to 30% of patients) [4–7].
The mechanisms by which CsA causes nephrotoxicity are not
well understood but are thought in part due to calcineurin
inhibition [8]. CsA causes acute reversible nephrotoxicity as well
as chronic, irreversible nephrotoxicity [7]. Acute CsA renal
toxicity is linked to increased renal vascular resistance due to
increased vasoconstrictors, decreased vasodilators, activation of
renal nerves, and mesangial cell contraction, hypoxia/reperfusion
(I/R) and free radical production [5,7,9–13]. Upregulation of toll-
like receptors (TLR) and TNF-a is also involved in CsA
nephrotoxicity [14]. Chronic CsA causes decreases of glomerular
filtration rates, tubulointerstitial injury, apoptosis, tubular micro-
calcification, arteriolar hyalinosis, fibrosis, and focal glomerular
sclerosis [7]. Mechanisms of CsA chronic damage are less clear
compared to the acute nephrotoxicity [7]. Cyclosporine A also
upregulates TGF-b expression [15].
Energy supply is essential for cell survival and function.
Mitochondrial dysfunction is a common cause of drug/toxicant-
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induced organ injury and CsA has profound effects on mitochon-
dria. At low concentrations/doses, CsA inhibits the opening of the
mitochondrial permeability transition (MPT) pores by binding to
cyclophilin D in the matrix and the inner membrane of
mitochondria, protecting against I/R injury [16–18]. However,
at high concentrations/doses, CsA inhibits mitochondrial respira-
tion and decreases ATP production in vivo and in vitro [19–21].
It is suspected that poor adaptation to altered mitochondrial
energy metabolism is linked to organ vulnerability to CsA toxicity
[19]. Mitochondrial biogenesis (MB) is an important adaptation,
counteracting mitochondrial dysfunction/toxicity. Calcineurin
plays an important role in the expression of peroxisome
proliferator-activated receptor-c coactivator (PGC)-1a [22–24],
the master regulator of MB. Whereas CsA is a potent calcineurin
inhibitor. it is possible that CsA suppresses MB to induce
nephrotoxicity.
Green tea polyphenols are free radical and singlet oxygen
scavengers. Beneficial effects of green tea polyphenols in the
prevention/treatment of cardiovascular, hepatic, renal, neural,
pulmonary and intestinal diseases, cancer, diabetes, arthritis,
shock, and decreases in ischemia/reperfusion injury and drug/
chemical toxicity in various organs/tissues have been widely
reported and many of these effects are presumably due to their
antioxidant and anti-inflammatory properties [25–40]. Our
previous study showed that a Camellia sinenesis (green tea) extract,
which contains high levels of plant polyphenols (e.g. epigalloca-
techin gallate, epigallocatechin, epicatechin, and catechin), atten-
uated CsA nephrotoxicity, in part, by scavenging free radicals
[31]. Recent studies showed that isoflavones are effective MB
stimulators and improve mitochondrial function after renal I/R
injury, diabetes, chronic heart failure, and aging [41–45].
Stimulation of MB increases mitochondrial proteins and mass,
improves function, and is an attractive strategy for promoting cell
repair and regeneration, preserving organ function and treating a
number of pathologies resulting from damage/inhibition of
mitochondrial function [42–50]. Thus, this study was designed
to explore the effects of green tea polyphenols on renal MB after
chronic CsA treatment.
Materials and Methods
Cyclosporin A and Polyphenol Treatments
CsA (Sandimmune oral solution) was obtained from Novartis
(Basel, Switzerland). Green tea extracts, produced by Taiyo
Kagaku Co. (Yokkaichi, Mie, Japan), contained 85% polyphenols
by weight. Components of polyphenols in the extract was
determined by high performance liquid chromatography (HPLC)
as described previously [31] and included epigallocatechin gallate
(47.2% of total polyphenols), epigallocatechin (11.0%), galloca-
techin gallate (11.0%), epicatechin gallate (10.8%), gallocatechin
(8.6%), epicatechin (8.4%), and catechin (3.0%).
Male Sprague-Dawley rats (200–250 g) were fed a semi-
synthetic powdered diet (AIN 76, Dyets Inc. Bethlehem, PA)
containing 0% or 0.1% green tea polyphenolic extract starting 3
days prior to and lasting throughout CsA or vehicle treatment.
Previous studies showed that 0.1% green tea extract in the diet
blunted CsA renal toxicity, hepatic I/R injury, cholestatic liver
fibrosis and inhibited development of renal cell tumors in rats
[29,31,40,51]. Daily food consumption was not different between
the groups with or without green tea polyphenolic extract
addition. Average polyphenolic extract intake calculated by the
daily food consumption and polyphenolic content in the diet was
,80 mg/kg/day. CsA oral solution or its vehicle (Cremophor EL
20 mg/ml in 12.5% dehydrated alcohol) was further diluted in
olive oil. Previous studies have shown that higher doses of CsA are
required in rats to cause renal damages that are similar to the
damages observed in humans [6,11,12]. Therefore, CsA (25 mg/
kg, 0.25 mL/100 g body weight) or an equivalent volume of
vehicles was gavaged daily for 21 days.
Serum Creatinine, Renal Histology and
Immunohistological Staining
At 21 days after CsA treatment, rats were anesthetized with
pentobarbital (50 mg/kg, i.p), and blood was collected from the
vena cava. Serum creatinine was determined using a kit from
Sigma-Aldrich Co. (St. Louis, MO). The left kidney was rinsed
with 5 ml normal saline, perfusion-fixed with 10% formaldehyde
in phosphate buffered saline, then removed and placed in the same
fixative for 48 h. Sections were stained with hematoxylin-eosin
(H&E) and analyzed microscopically for pathological changes.
Apoptosis was assessed by terminal deoxynucleotidyl transferase
dUTP nick-end labeling (TUNEL) using an in situ cell death
detection kit from Roche Diagnostics (Penzberg, Germany) [52].
Tubules in the cortex with and without injury (vacuolization, loss
of brush border, dilatation, necrosis, atrophy, and calcification),
leukocytes, and TUNEL-positive cells were counted in a blinded
manner in 10 randomly selected fields per slide under a Nikon
Optiphot-2 microscope (Nikon Instruments Inc., Melville, NY)
using a 40x objective lens after H&E and TUNEL staining,
respectively. Renal fibrosis was detected using the Masson’s
Trichrome staining. Immunohistological staining of cytochrome c
oxidase subunit IV (COX-IV), a nuclear DNA (nDNA)-encoded
mitochondrial oxidative phosphorylation (OXPHOS) protein, was
performed as described elsewhere [53] using a specific antibody
against COX-IV at a dilution of 1:200.
Detection of Mitochondrial DNA (mtDNA) Copy Number,
ATP Synthase-b (AS-b), NADH Dehydrogenase-3 (ND3),
PGC-1a, and Mitochondrial Transcription Factor A (Tfam)
mRNAs by Quantitative Real-time PCR (qPCR)
Relative quantities of mtDNA content in the kidney were
determined using qPCR [46]. Total genomic DNA was extracted
using a DNeasy Blood and Tissue kit (Qiagen, Valencia, CA).
Mitochondrial DNA copy number was assessed by quantification
of mtDNA-encoded NADH dehydrogenase-1 (ND1) gene using a
CFX96 Real Time-PCR Detection System (Bio-Rad, Hercules,
CA) and normalized against the nuclear-encoded POU class 5
homeobox 1 (Pou5f1) gene. Primer sequences used are listed in
Table 1.
Quantitative real-time PCR of mRNAs was performed as
described elsewhere [54]. After total RNA isolation from kidney
tissue with Trizol (Invitrogen, Grand Island, NY), single stranded
cDNAs were synthesized from RNA (2 mg) using a Bio-Rad iScript
cDNA Synthesis kit (Bio-Rad, Hercules, CA). Quantitative real-
time PCR was conducted using the primer sequences in Table 1.
The abundance of mRNAs was normalized against hypoxanthine
phospho-ribosyl-transferase (HPRT) using the DDCt method.
Immunoprecipitation of PGC-1a
Immunoprecipitation was performed as described elsewhere
[55]. Kidneys were homogenized and extracted in ice-cold lysing
buffer. Immunoprecipitations were carried out with protein lysate
(500 mg protein as determined by the Bradford assay) and PGC-1a
antibody (5 mg) using a Catch and Release v2.0 Reversible
Immunoprecipitation System (Millipore, Billerica, MA). Protein
content in the immunoprecipitates was determined by the
Bradford assay. Acetylated lysine residues and PGC-1a were
Polyphenols & Renal Mitochondrial Biogenesis
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determined by immunoblotting [54] using corresponding specific
antibodies (Cell Signaling Technology, Danvers, MA and Santa
Cruz Biotech., Santa Cruz, CA, respectively).
Immunoblotting
Proteins in renal tissue extracts were detected by immunoblot
analysis as previously described [54] using primary antibodies
specific for AS-b, neutrophil gelatinase-associated lipocalin
(NGAL), Tfam (GenWay Biotech, San Diego, CA), cleaved
caspase-3 (Cell Signaling Technology, Danvers, MA), ND3 and
PGC-1a (Santa Cruz Biotech., Santa Cruz, CA) at concentrations
of 1:100 to 1000, and actin (ICN, Costa Mesa, CA) at a
concentration of 1:3000 at 4uC over night, respectively. Horse-
radish peroxidase-conjugated secondary antibodies were applied
afterwards, and detection was by chemiluminescence (Pierce
Biotec., Rockford, IL).
Statistical Analysis
Groups were compared using ANOVA plus a Student-New-
man-Keuls posthoc test. There were 4 rats per group for all
parameters. Data shown are means6S.E.M. Differences were
considered significant at p,0.05.
Ethics Statement
All animals were given humane care in compliance with
institutional guidelines using protocols approved by the Institu-
tional Animal Care and Use Committee of the University of North
Carolina. All surgery was performed under sodium pentobarbital
anesthesia (50 mg/kg, i.p.).
Results
CsA Decreases mtDNA Copy Number in the Kidney:
Reversal by Green Tea Polyphenols
CsA treatment causes changes in high-energy phosphate
homeostasis in tissues [19–21]. Mitochondrial DNA is responsible
for synthesis of crucial mitochondrial OXPHOS proteins, and
proper function of mitochondrial respiration requires an adequate
copy number of mtDNA per cell [49,56]. Therefore, we examined
the alterations in mtDNA in the kidney after vehicle and CsA
treatment. Renal mtDNA copy number decreased by 78% after
chronic CsA treatment (Fig. 1). Polyphenols increased mtDNA
copy number by 19% in rats treated with the vehicle and
recovered mtDNA copy number to ,90% of control levels after
chronic CsA treatment (Fig. 1).
CsA Decreases Mitochondrial OXPHOS Proteins in the
Kidney: Reversal by Green Tea Polyphenols
The majority of mitochondrial proteins are encoded by nuclear
DNA (nDNA) [56,57]. We examined a subunit of F0F1ATPase,
AS-b, that is encoded by nDNA after chronic CsA treatment. CsA
decreased AS-b by 48% (Fig. 2A,B). Polyphenols increased AS-b
15% above control levels in the kidneys from vehicle-treated rats
and recovered AS-b to ,91% of control levels in the kidneys from
CsA-treated rats. ND3, a mtDNA-encoded mitochondrial OX-
PHOS protein, decreased 88% after chronic CsA treatment
(Fig. 2A,C). Polyphenols increased ND3 to 31% above control
levels in the kidneys of vehicle-treated rats and recovered ND3 to
61% of control levels in the kidneys of CsA-treated rats (Fig. 2A,C).
Expression of COX-IV, a nDNA-encoded mitochondrial
OXPHOS protein, was observed in various renal cells by
immunohistochemical staining (Fig. 2D). In control rats,
immunoreactivity of COX-IV was localized throughout the
tubular cells in kidney cortex and the medulla, particularly in
the proximal tubules. COX-IV staining in tubular cells was
punctate, consistent with mitochondrial localization. In contrast,
immunoreactivity of COX-IV was low in glomeruli (data not
shown). After CsA treatment, COX-IV immunoreactivity
decreased substantially in tubular cells in the cortex and
Table 1. Real-Time PCR Primers.
DNAs/mRNAs Primers
AS-b Forward: 59- TTG CTG AGG TCT TCA CAG GTC ACA-
39
Reverse: 59- CAG CCT TTG CCA CAG CTT CTT CAA-39
ND1 Forward: 59- TTA ATT GCC ATG GCC TTC CTC ACC-39
Reverse: 59- TGG TTA GAG GGC GTA TGG GTT CTT-
39
ND3 Forward: 59- CAA CAA GTT CTG CAC GCC TTC CTT-39
Reverse: 59- TTG TTT GAA TCG CTC ATG GGA GGG-
39
Tfam Forward: 59- GAT GAG TCA CCT CAA GGG AAA TTG-
39
Reverse: 59- GTC ATC TAG TAA AGC CCG GAA GGT-
39
Pou5f1 Forward: 59- AGG TGT TCA GCC AGA CAA CCA TCT-
39
Reverse: 59- TCT CGT TGT TGT CAG CTT CCT CCA-39
HPRT Forward 59- TCG AAG TGT TGG ATA CAG GCC AGA-
39
Reverse: 59-TAC TGG CCA CAT CAA CAG GAC TCT-39
AS-b, ATP synthase-b; ND1, NADH dehydrogenase-1; ND3, NADH
dehydrogenase-3; Tfam, mitochondrial transcription factor-A; Pou5f1, POU class
5 homeobox 1; HPRT, hypoxanthine phospho-ribosyl-transferase.
doi:10.1371/journal.pone.0065029.t001
Figure 1. Decreases of mitochondrial DNA copy numbers by
cyclosporin A (CsA): reversal by green tea polyphenols. Rats
were fed semi-synthetic powdered diets containing 0% (control) or
0.1% polyphenol extracts (polyphenols) starting 3 days prior to CsA
treatment (25 mg/kg, i.g. for 3 weeks). Renal mitochondrial DNA copy
numbers were determined by qPCR. a, p,0.05 vs. control diet+vehicle;
b, p,0.05 vs. polyphenol-containing diet+vehicle; c, p,0.05 vs. control
diet+CsA (n = 4 per group).
doi:10.1371/journal.pone.0065029.g001
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medulla. Polyphenols increased COX-IV immunoreactivity in
tubular cells after CsA treatment.
CsA Decreases AS-b and ND3 mRNAs in the Kidney:
Recovery by Green Tea Polyphenols
Since AS-b and ND3 were decreased by CsA, we investigated
the mRNA levels of these proteins. AS-b mRNA decreased 55%
by CsA treatment (Fig. 3A). Polyphenols increased AS-b mRNA
22% above control levels in the kidneys of vehicle-treated rats and
recovered AS-b mRNA to 89% of control values in the kidneys of
CsA-treated rats. Renal ND3 mRNA was 64% lower in CsA-
treated rats compared to vehicle-treated rats (Fig. 3B). ND3
mRNA increased 21% in vehicle-treated rats and recovered to
,90% of control values in CsA-treated rats. Together, we suggest
that decreases in AS-b and ND3 proteins are due, at least in part,
to suppression of their mRNAs and these effects were reversed by
green tea polyphenols.
Green Tea Polyphenols Increase PGC-1a mRNA and
Activation after CsA Treatment
PGC-1a plays a key role in the control of MB and mtDNA
maintenance [58]. We investigated whether CsA alters PGC-1a
levels in the kidney. PGC-1a was 42% lower in the kidneys of
CsA-treated than vehicle-treated rats (Fig. 4A and B). Polyphe-
nols increased PGC-1a by 34% in the kidneys of vehicle-treated
rats and increased PGC-1a to control levels in the kidneys of
CsA-treated rats. We further examined whether polyphenols
increased PGC-1a mRNA. CsA decreased PGC-1a mRNA by
67% (Fig. 4C). Polyphenols slightly increased PGC-1a mRNA
in the kidneys of vehicle-treated rats and recovered PGC-1a
mRNA in the kidneys of CsA-treated rats to 87% of control
levels.
PGC-1a activity is higher after de-acetylation [46]. PGC-1a was
immunoprecipitated and acetylated lysine residues were detected
by immunoblotting (Fig. 5A and B). Acetylation of PGC-1a was
increased substantially after chronic CsA treatment and polyphe-
Figure 2. Decreases of mitochondrial oxidative phosphorylation proteins by CsA: reversal by green tea polyphenols. Rats were fed
semi-synthetic powdered diets containing 0% (Control) or 0.1% polyphenol extracts (Polyphenols) starting 3 days prior to CsA treatment (25 mg/
kg, i.g. for 3 weeks). Renal mitochondrial oxidative phosphorylation proteins ATP synthase-b (AS-b, 55 kDa) and NADH dehydrogenase-3 (ND3,
24 kDa) were determined by immunoblotting and representative images are shown in A. AS-b (B) and ND3 (C) were quantified by densitometry. a,
p,0.05 vs. control diet+vehicle; b, p,0.05 vs. polyphenol-containing diet+vehicle; c, p,0.05 vs. control diet+CsA (n = 4 per group). Cytochrome c
oxidase subunit IV was detected by immunohistochemistry (D). Representative images of 4 rats per group are shown.
doi:10.1371/journal.pone.0065029.g002
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nols decreased acetylation of PGC-1a, indicating enhanced PGC-
1a activation.
Green Tea Polyphenols Increase Tfam Synthesis after CsA
Treatment
Tfam is a transcription factor that regulates the replication
and transcription of the mitochondrial genome, thus playing a
critical role in controlling MB [59]. Tfam decreased by almost
90% after CsA treatment (Fig. 6A and B), consistent with
decreased mtDNA copy number and mtDNA-encoded ND3
transcription. Expression of Tfam is controlled by PGC-1a [59].
Consistent with decreased PGC-1a expression and activity,
Tfam mRNA also decreased after CsA treatment (Fig. 6C),
indicating suppressed Tfam transcription. Polyphenols elevated
renal Tfam mRNA and protein modestly in vehicle-treated rats
and largely reversed the decreases of renal Tfam mRNA and
protein in CsA-treated rats.
Green Tea Polyphenols Attenuate Kidney Injury and
Improve Kidney Function after CsA Treatment
Renal histology was examined after treatment with CsA for 3
weeks (Fig. 7). The kidneys of rats on the control and polyphenol
diets that received vehicle treatment exhibited normal histology (A
and B). CsA treatment caused a loss of brush border and dilatation
of proximal tubules (C), tubular atrophy (C and F), vacuolization
(E), calcification (G), cast formation, arteriolar hyalinosis (H) and
leukocyte infiltration, most overtly in the cortex, consistent with
previous reports [31,60]. Pathological changes occurred in 39% of
tubules in the cortex and leukocytes increased from 10/high power
field (hpf) to 66/hpf after CsA treatment (Fig. 8A,B). Polyphenols
decreased tubular injury after CsA treatment to 7% and leukocyte
to 25/hpf (Fig. 8 A,B).
Cleaved caspase-3 was barely detectable in the kidneys from
vehicle-treated rats with or without polyphenol treatment. CsA
increased cleaved caspase about 7-fold (Fig. 8C) and this effect was
largely blunted by polyphenols. TUNEL-positive cells in the cortex
were 0.5–0.8/hpf in vehicle-treated rats with or without polyphe-
nol treatment. TUNEL-positive cells increased to ,14/hpf after
CsA treatment in the absence of polyphenols and was decreased to
3/hpf in the presence of polyphenols (Fig. 8D). These data show
that CsA caused apoptosis and this effect was blunted by
polyphenols.
Renal fibrosis was revealed using Masson’s Trichrome staining
(Fig. 9). In the kidneys from vehicle-treated rats with or without
polyphenol treatment, Trichrome staining was rare in the
Figure 3. Decreases of ATP synthase-b and NADH dehydroge-
nase-3 mRNAs by CsA: reversal by green tea polyphenols. Rats
were fed semi-synthetic powdered diets containing 0% (Control) or
0.1% polyphenol extracts (Polyphenols) starting 3 days prior to CsA
treatment (25 mg/kg, i.g. for 3 weeks). Renal ATP synthase-b (AS-b) and
NADH dehydrogenase-3 (ND3) mRNAs determined by qPCR are shown
in A and B, respectively. a, p,0.05 vs. control diet+vehicle; b, p,0.05
vs. polyphenol-containing diet+vehicle; c, p,0.05 vs. control diet+CsA
(n = 4 per group).
doi:10.1371/journal.pone.0065029.g003
Figure 4. Suppression of peroxisome-proliferator-activated
receptor gamma coactivator-1a (PGC-1a) expression by CsA:
reversal by green tea polyphenols. Rats were fed semi-synthetic
powdered diets containing 0% (Control) or 0.1% polyphenol extracts
(Polyphenols) starting 3 days prior to CsA treatment (25 mg/kg, i.g.
for 3 weeks). Renal PGC-1a (90 kDa) and actin (43 kDa) were
determined by immunoblotting. Representative images are shown in
A and quantification by densitometry is shown in B. PGC-1a mRNA was
determined by qPCR (C). a, p,0.05 vs. control diet+vehicle; b, p,0.05
vs. polyphenol-containing diet+vehicle; c, p,0.05 vs. control diet+CsA
(n = 4 per group).
doi:10.1371/journal.pone.0065029.g004
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interstitium. A small amount of blue Trichrome staining appeared
in the brush borders, perhaps reflecting the microfilaments in the
microvilli of tubular cells. After CsA treatment, blue staining in the
brush borders of tubular cells disappeared and was replaced with
wide-spread interstitial fibrosis, most overtly in the cortex but also
observable in the medulla. Thickening of Bowman’s capsule also
occurred in some glomeruli. Renal fibrosis was blunted markedly
by polyphenols.
Neutrophil gelatinase-associated lipocalin (NGAL), a sensitive
marker of acute kidney injury and a potential indicator of chronic
kidney disease progression [61–64], was barely detectable in
vehicle-treated rats with or without polyphenol treatment. NGAL
increased by 5.5-fold after CsA treatment (Fig. 10 A and B). This
effect was blunted by polyphenols.
Serum creatinine was 0.47 mg/dL in vehicle-treated rats and
was not altered by polyphenols alone (Fig. 10C). After CsA
treatment, serum creatinine increased to 1.4 mg/dL and poly-
phenols decreased serum creatinine to 0.78 mg/dL in CsA-treated
rats. Together, CsA-induced pathological changes in the kidney
were consistent with tubulointerstitial injury and these effects were
markedly attenuated by polyphenols.
Discussion
Suppression of MB by CsA Treatment
The calcineurin inhibitor CsA is the basis for many immuno-
suppressive protocols, but its adverse effects (i.e. severe nephro-
toxicity) are a major barrier in long-term immunosuppressive
therapy [4,5,7]. The mechanisms of CsA nephrotoxicity are not
well understood. CsA at high concentrations inhibits respiration
and damages proteins and lipids in isolated mitochondria
[17,65,66]. After in vivo treatment CsA decreases ATP levels in
the rat kidney [19,21]. Decreased oxidative phosphorylation could
cause cell damage and inhibit renal function. Another important
side effect of CsA, neurotoxicity, is linked to decreased mitochon-
drial metabolism [20,67].
Mitochondrial homeostasis is crucial for maintaining proper
energy supply and function of tissues. The abundance of
mitochondria in a cell is determined by biogenesis, fission/fusion,
and mitophagy [56]. When increased tissue energy demand
exceeds mitochondrial ATP-producing capacity (e.g. exercise) or
replacement of damaged mitochondria is needed, MB is stimu-
lated. Mitochondria cannot be made de novo but require synthesis
of new organelle constituents and the integration of these
components (i.e., proteins and lipids) into preexisting mitochon-
dria. MB requires synthesis and import of nDNA-encoded
OXPHOS proteins (e.g. AS-b and COX-IV) into mitochondria
as well as expression of mtDNA-encoded OXPHOS proteins (e.g.
ND3) [56,68,69]. Suppression of MB could sensitize a tissue to
toxicants and diseases.
Figure 5. Suppression of peroxisome proliferator-activated
receptor gamma coactivator-1a (PGC-1a) activation by CsA:
reversal by green tea polyphenols. Rats were fed semi-synthetic
powdered diets containing 0% (Control) or 0.1% polyphenol extracts
(Polyphenols) starting 3 days prior to CsA treatment (25 mg/kg, i.g.
for 3 weeks). Renal PGC-1a was immunoprecipitated, equally loaded,
and acetylated lysine (Ac-Lys) and PGC-1a were determined by
immunoblotting. Representative images are shown in A and quantifi-
cation by densitometry is shown in B. a, p,0.05 vs. control diet+vehicle;
b, p,0.05 vs. polyphenol-containing diet+vehicle; c, p,0.05 vs. control
diet+CsA (n = 4 per group).
doi:10.1371/journal.pone.0065029.g005
Figure 6. Suppression of mitochondrial transcription factor A
(Tfam) expression by CsA: reversal by green tea polyphenols.
Rats were fed semi-synthetic powdered diets containing 0% (Control)
or 0.1% polyphenol extracts (Polyphenols) starting 3 days prior to CsA
treatment (25 mg/kg, i.g. for 3 weeks). Renal Tfam protein (30 kDa) was
determined by immunoblotting. Representative images are shown in A
and quantification by densitometry is shown in B. Tfam mRNA was
determined by qPCR (C). a, p,0.05 vs. control diet+vehicle; b, p,0.05
vs. polyphenol-containing diet+vehicle; c, p,0.05 vs. control diet+CsA
(n = 4 per group).
doi:10.1371/journal.pone.0065029.g006
Polyphenols & Renal Mitochondrial Biogenesis
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A previous study showed that low dose of CsA protected against
doxorubicin-induced heart dysfunction but did not alter MB [70].
In contrast, we observed that after chronic CsA treatment,
mtDNA copy number was decreased substantially (Fig. 1), which
was accompanied by a marked reduction in nDNA- and mtDNA-
encoded OXPHOS proteins and their associated mRNAs (Figs. 2–
3). Taken together, these data are consistent with the conclusion
that renal MB is suppressed after CsA treatment.
CsA Treatment Decreases PGC-1a Expression and Activity
MB is tightly regulated by a signaling system connecting
different pathways [49,71–74]. The transcriptional coactivators
(PGC-1a and b) and the PGC-1-related coactivator (PRC)
modulate the expression of target genes encoding OXPHOS
enzymes [58,75,76]. PGC-1a induces and coordinates expres-
sion of nuclear regulatory proteins (e.g. nuclear respiratory
factor (NRF)-1 and NRF-2) that activate target genes encoding
OXPHOS proteins, PGC-1a itself, and Tfam. Tfam is a
transcription factor that acts on the promoters within the non-
coding (D-loop) region of mtDNA and regulates the replication
and transcription of the mitochondrial genome [59,77]. Over-
expression of PGC-1a leads to mitochondrial proliferation in
the heart, adipocytes, myoblasts and renal proximal tubular cells
[47,50,76,78,79]. AMP-activated kinase (AMPK), sirtuin 1
(SIRT1), nitric oxide and cGMP, and other signaling kinases
(e.g. Ca2+/calmodulin-stimulated protein kinase (CaMK), p38
MAPK and protein kinase C) regulate PGC-1a expression and/
or activity [80–84].
Studies showed that calcineurin activation increases PGC-1a
gene transcription [22]. Also, over-expression of constitutively
active calcineurin in mouse skeletal muscle or cardiac myocytes
leads to increased expression of PGC-1a [23,24]. A coordinate
increase of PGC-1a and its downstream transcription factors as
well as gene expression of mitochondrial proteins were observed
in association with calcineurin activation in human muscle after
long term exercise [85]. PGC-1a and calcineurin activation also
Figure 7. Dietary polyphenols minimize CsA-induced pathological changes in the kidney. Rats were fed semi-synthetic powdered diets
containing 0% (Control) or 0.1% polyphenol extracts (Polyphenols) starting 3 days prior to CsA treatment (25 mg/kg, i.g. for 3 weeks).
Representative images of H&E-stained kidney sections are shown. A, control diet plus vehicle; B, 0.1% polyphenols plus vehicle; C, E, F, G, and H,
control diet plus CsA; D, polyphenols plus CsA. E, tubular cell vacuolization; F, tubular atrophy; G, calcification; H, arteriolar hyalinosis.
doi:10.1371/journal.pone.0065029.g007
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play an important role in MB in both healthy and diseased
human skeletal muscles [85,86]. Calcineurin stimulates members
of the myocyte enhancer factor 2 (MEF2) family of transcription
factors which bind to and activate the PGC-1a promoter and
enhance a positive feedback loop between PGC-1a and MEF2
in muscle [22,87]. In contrast, little is known concerning the
effects of calcineurin inhibition on MB and mitochondrial
homeostasis. In this study chronic exposure to CsA altered
PGC-1a signaling in the kidney by decreasing PGC-1a protein
and mRNA, and increasing PGC-1a acetylation (Figs. 4–5).
PGC-1a also controls the expression of Tfam and Tfam
decreased after CsA treatment (Fig. 6), consistent with decreased
mtDNA copy number and suppressed expression of mtDNA-
encoded ND3 (Figs. 1 and 3). In total, these data are consistent
with PGC-1a depletion mediated suppression of MB. Because
mitochondria are abundant in proximal tubular cells, decreases
in mitochondrial OXPHOS proteins and pathological changes
after CsA treatment were most overt in these cells (Figs. 2, 7
and 8).
Green Tea Polyphenols Enhance MB after CsA Treatment
Stimulation of MB could counteract disease- or toxicant-
induced mitochondrial suppression, enhance recovery of mito-
chondrial function, decrease tissue injury and promote tissue
repair and regeneration. Some natural and synthetic molecules
have been found to stimulate MB, such as small molecule SIRT1
activators, nitric oxide, isoflavones, b2-adrenergic receptor ago-
nists, AMPK activators, cAMP and cGMP analogues, and 1-(2,5-
dimethoxy-4-iodophenyl)-2-aminopropane [41,46,88–92]. Epica-
techin improves MB and attenuates mitochondrial dysfunction in
rodents and in patients with diabetes and chronic heart failure
[42,43]. Epicatechin also enhances fatigue resistance and oxidative
capacity in aged mouse muscle [44]. Here we investigated the
effect of green tea polyphenols, which was shown to protect against
CsA nephrotoxicity [31], on MB. Polyphenols increased molecules
regulating MB (PGC-1a, Tfam), mtDNA and OXPHOS proteins
in control and CsA-treated rats, and these effects were associated
with decreased kidney injury and improved renal function after
CsA treatment (Figs. 7, 8, 9, 10). Therefore, in addition to their
effects as antioxidants, green tea polyphenols may also protect
and/or promote renal function by stimulating MB.
Interestingly, in addition to increasing PGC-1a mRNA and
protein, polyphenols also increased PGC-1a activation as indicat-
ed by decreased acetylated PGC-1a (Fig. 5). This reduction in
acetylated PGC-1a was not due to decreased PGC-1a protein
since PGC-1a was equally loaded in the gels for immunoblotting
after immunoprecipitation. A similar effect was observed in
isoflavone-treated renal proximal tubular cells, isoflavones in-
creased activity and protein content of SIRT1, a member of the
histone deacetylase (HDAC) family [41]. Green tea polyphenol
epigallocatechin gallate also increases HDAC activity and HDAC-
2 expression in regulatory T cells [93]. Thus polyphenols may
Figure 8. Dietary polyphenols minimize CsA-induced tubular injury and leukocyte infiltration in the cortex. Rats were fed semi-
synthetic powdered diets containing 0% (Control) or 0.1% polyphenol extracts (Polyphenols) starting 3 days prior to CsA treatment (25 mg/kg, i.g.
for 3 weeks). Tubules with and without injury, leukocytes, and TUNEL-positive cells in the cortex were counted in a blinded manner in 10 randomly
selected fields per slide using a 40x objective lens after H&E and TUNEL staining, respectively. Percentages of tubules with injury are shown in A. The
average numbers of leukocytes and TUNEL-positive cells per high power field (hpf) are shown in B and D, respectively. Cleaved caspase-3 (CC3) in
kidney tissue was detected by immunoblotting (17 kDa) and quantified by densitometry (C). a, p,0.05 vs. control diet+vehicle; b, p,0.05 vs.
polyphenol-containing diet+vehicle; c, p,0.05 vs. control diet+CsA (n = 4 per group).
doi:10.1371/journal.pone.0065029.g008
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increase SIRT1 activity, decrease PGC-1a protein acetylation and
increase PGC1a transcription.
A recent study showed that green tea polyphenols can bind to
and stimulate a 67-kDa laminin receptor, leading to activation of
NADPH oxidase and generation of reactive oxygen species in
PC12 cells subjected to oxygen-glucose deprivation [94]. Red wine
polyphenols at a low concentration but not at a high concentration
stimulated MB and angiogenesis, and this effect depended on the
estrogen receptor-a activation [95]. However, it is unclear whether
estrogen receptor-a activation by red wine polyphenols is a direct
Figure 9. Dietary polyphenols attenuate CsA-induced renal fibrosis. Rats were fed semi-synthetic powdered diets containing 0% (Control)
or 0.1% polyphenol extracts (Polyphenols) starting 3 days prior to CsA treatment (25 mg/kg, i.g. for 3 weeks). Representative images of Trichrome-
stained kidney sections are shown. 1st row, control diet plus vehicle; 2nd row, 0.1% polyphenols plus vehicle; 3rd row, control diet plus CsA; 4th
row, polyphenols plus CsA (n = 4 per group).
doi:10.1371/journal.pone.0065029.g009
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or indirect effect. As discussed above, isoflavones have been shown
to increase SIRT1 activity and protein content and may induced
MB through this mechanism. In the present study, polyphenols
increased MB in tubular cells which originally have abundant
mitochondria but did not increase MB in glomeruli which have
lower levels of mitochondria, and this stimulation of MB depended
on the PGC-1a signaling pathway. Whether polyphenols act
directly or indirectly to increase MB and whether this stimulation
of MB requires binding of polyphenols to a specific receptor
remain to be investigated.
The green tea extract contains several polyphenols. The major
polyphenol in the extract was epigallocatechin gallate (,50%).
Our previous studies showed that epicatechin and epicatechin
gallate had similar protective effects on liver ischemia/reperfusion
injury and liver transplantation as green tea extracts containing
multiple polyphenol components [29,30]. In some other studies,
the relative activities of the various polyphenolic components to
inhibit oxidation and injury were variable [96]. It was also shown
that a combination of epigallocatechin gallate, epicatechin gallate,
epigallocatechin, and epicatechin in the molar ratio 5:2:2:1
provided optimal protective effects against lipid peroxidation
[97]. Studies should be performed in the future to evaluate the
efficacies of each polyphenolic component and various combina-
tions of polyphenols on MB in cultured renal cells and in vivo.
Conclusion
Taken together, MB is suppressed in the kidney after chronic
CsA treatment, which may contribute to the development of CsA
nephrotoxicity. Green tea polyphenols protect against CsA
nephrotoxicity, at least in part, by enhancing MB.
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